Co-Diagnostics, Inc. Shareholders' Equity
Co-Diagnostics, Inc. (CODX) had Shareholders' Equity of $12.71 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $12.71M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $16.04M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $20.63M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $39.83M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $12.71M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $16.04M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $20.63M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $39.83M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $40.70M 10-Q · filed 2026-08-13 | $41.14M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $47.48M 10-Q · filed 2026-08-13 | $47.92M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $53.88M 10-Q · filed 2026-08-13 | $54.31M 10-K · filed 2025-03-27 |
| 2024-09-30 | $63.78M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $72.40M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $78.35M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $85.58M 10-K · filed 2026-03-31 | $86.01M 10-K · filed 2024-03-14 |
| 2023-09-30 | $99.49M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $103.43M 10-Q · filed 2024-11-07 | $103.43M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $110.63M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $114.52M 10-K · filed 2025-03-27 | $114.52M 10-K · filed 2023-03-16 |
| 2022-09-30 | $134.95M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $144.47M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $147.71M 10-Q · filed 2023-11-09 | $147.71M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $134.48M 10-K · filed 2024-03-14 | $134.48M 10-K · filed 2022-03-24 |
| 2021-09-30 | $100.16M 10-Q · filed 2022-11-10 | $100.16M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $87.27M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $76.26M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $66.70M 10-K · filed 2023-03-16 | |
| 2020-09-30 | $52.78M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $35.73M 10-Q · filed 2021-11-12 | $33.36M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $19.17M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $1.74M 10-K · filed 2022-03-24 | |
| 2019-09-30 | $3.33M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $4.81M 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $5.56M 10-Q · filed 2020-11-16 | |
| 2018-12-31 | -$1.06M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $127.35K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $1.24M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $2.57M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $3.85M 10-K · filed 2020-03-30 | |
| 2017-09-30 | $5.19M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$4.40M 10-Q · filed 2017-08-25 | |
| 2016-12-31 | -$2.99M 10-K · filed 2019-04-01 | |
| 2015-12-31 | -$1.15M 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |